These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 888485)

  • 1. [Biotransformation and its modification by barbiturates].
    Remmer H
    Z Gastroenterol; 1977 Jun; 15(6):362-72. PubMed ID: 888485
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug interactions. 3. Therapeutic implications of enzyme induction.
    Soyka LF
    Pediatrics; 1972 Sep; 50(3):489-90. PubMed ID: 5056430
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of the unspecific microsomal hydroxylase in the human liver.
    Remmer H; Schoene B; Fleischmann RA
    Drug Metab Dispos; 1973; 1(1):224-30. PubMed ID: 4149387
    [No Abstract]   [Full Text] [Related]  

  • 4. [Stimulation and inhibition of hexobarbital metabolism by previous administration of phenobarbital and nikethamide].
    Malgor LA; Verbes V; De Klainer EG
    Medicina (B Aires); 1971 Jun; 31(3):205-9. PubMed ID: 5099340
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metabolism of phenylbutazone in the liver (author's transl)].
    González Macías J; De Castro del Pozo S
    Med Klin; 1976 Sep; 71(36):1434-8. PubMed ID: 958107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of diphenylhydantoin on primidone metabolism.
    Fincham RW; Schottelius DD; Sahs AL
    Trans Am Neurol Assoc; 1973; 98():197-9. PubMed ID: 4784933
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interactions between phenprocoumon (Marcumar) and drug-catabolizing, enzyme system-inducing pharmaceutic agents].
    Heni N; Völger R; Glogner P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1579-82. PubMed ID: 347786
    [No Abstract]   [Full Text] [Related]  

  • 8. [The mechanism of barbiturate induction of enzyme systems metabolizing medicinal compounds (review of the literature)].
    Sergeev PV; Vedernikova NN; Maĭskiĭ AI; Archakov AI
    Farmakol Toksikol; 1973; 36(3):365-71. PubMed ID: 4151005
    [No Abstract]   [Full Text] [Related]  

  • 9. The development of hepatic biotransformation (ethylmorphine-N-demethylation and ethoxycoumarin-O-deethylation) and their inducibility by phenobarbital in male rats delivered prematurely by caesarean section.
    Glöckner R; Klinger W; Karge E
    Z Versuchstierkd; 1986; 28(4):173-8. PubMed ID: 3490725
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum beta-glucuronidase activity in patients treated with phenobarbital and diphenylhydantoin].
    Tutor JC; Fernández MP; Paz JM
    Arch Farmacol Toxicol; 1982 Apr; 8(1):37-44. PubMed ID: 7138085
    [No Abstract]   [Full Text] [Related]  

  • 11. Protective effect of drug metabolism inducer and inhibitor on O,O,S-trimethyl phosphorothioate induced delayed toxicity in rats.
    Imamura T
    Proc West Pharmacol Soc; 1984; 27():155-61. PubMed ID: 6494150
    [No Abstract]   [Full Text] [Related]  

  • 12. [Induction studies in mice on the significance of liver metaboism in the termination of the effect of injectable narcotics].
    Buzello W; Scholler KL; Fritschi E
    Arzneimittelforschung; 1972 Dec; 22(12):2117-9. PubMed ID: 4679181
    [No Abstract]   [Full Text] [Related]  

  • 13. [Synthetic steroids that inhibit the intensified biotransformation of steroid hormones caused by the prolonged administration of phenobarbital to animals].
    Nedel'kina SV; Argutinskaia SV; Kusmartseva LP; Kamernitskiĭ AV; Turuta AM
    Vopr Med Khim; 1974; 20(2):142-8. PubMed ID: 4450512
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of liver enzyme induction caused by phenobarbital on the biotransformation of hetacillin in male rats.
    Galanpoulou P; Karageorgiou C; Kouvaris M; Varonos D
    J Antimicrob Chemother; 1980 Jan; 6(1):157-9. PubMed ID: 7358613
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticonvulsant pharmacokinetics.
    Breckenridge A
    Proc R Soc Med; 1974 Jan; 67(1):63-4. PubMed ID: 4595345
    [No Abstract]   [Full Text] [Related]  

  • 16. Medically resistant epilepsy: low levels of drugs in the brain or pharmacological inefficacy?
    Sironi VA; Ravagnati L; Ettorre G
    Acta Neurol (Napoli); 1984 Jun; 6(3):204-9. PubMed ID: 6475587
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug metabolism and interaction with particular reference to the liver.
    Cooksley WG; Powell LW
    Drugs; 1971; 2(3):177-89. PubMed ID: 4947120
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo effects of the cytochrome P-450 suicide substrate 2-isopropyl-4-pentenamide (allylisopropylacetamide) on the disposition and metabolic pattern of propranolol.
    Silber B; Mico BA; Ortiz de Montellano PR; Dols DM; Riegelman S
    J Pharmacol Exp Ther; 1981 Oct; 219(1):125-33. PubMed ID: 7288600
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of the hydrosoluble vitamin content of the diet and treatment by barbiturates on several effects of azoic dyes].
    Albrecht R; Manchon P
    Ann Nutr Aliment; 1973; 27(4):191-212. PubMed ID: 4151880
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modification of the action of drugs by inhibition of their metabolism].
    Park BK; Breckenridge AM; Ohnhaus EE
    Recenti Prog Med; 1979 Sep; 67(3):313-45. PubMed ID: 42953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.